These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18771970)

  • 1. Nuchal fold and nasal bone: how should we use them in Down syndrome screening?
    Wapner RJ
    Am J Obstet Gynecol; 2008 Sep; 199(3):213-4. PubMed ID: 18771970
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening.
    Odibo AO; Sehdev HM; Gerkowicz S; Stamilio DM; Macones GA
    Am J Obstet Gynecol; 2008 Sep; 199(3):281.e1-5. PubMed ID: 18771983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
    Sonek J; Cicero S; Nicolaides K
    Am J Obstet Gynecol; 2007 Jan; 196(1):e19. PubMed ID: 16996461
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal nasal bone assessment in first trimester down syndrome screening.
    Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
    Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of fetal nasal bone examination in the assessment of risk for trisomy 21 in clinical practice?
    Ville Y
    Am J Obstet Gynecol; 2006 Jul; 195(1):1-3. PubMed ID: 16813740
    [No Abstract]   [Full Text] [Related]  

  • 7. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
    Bethune M
    Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study.
    Cicero S; Curcio P; Papageorghiou A; Sonek J; Nicolaides K
    Lancet; 2001 Nov; 358(9294):1665-7. PubMed ID: 11728540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment.
    Orlandi F; Bilardo CM; Campogrande M; Krantz D; Hallahan T; Rossi C; Viora E
    Ultrasound Obstet Gynecol; 2003 Jul; 22(1):36-9. PubMed ID: 12858300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the second trimester genetic sonogram in screening for fetal Down syndrome.
    Benacerraf BR
    Semin Perinatol; 2005 Dec; 29(6):386-94. PubMed ID: 16533652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional performance of nasal bone in first trimester screening.
    Kozlowski P; Knippel AJ; Froehlich S; Stressig R
    Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Likelihood ratios to apply for nasal bone, ductus venosus and tricuspid flow at the 11-13 weeks' scan in down syndrome screening.
    Illa M; Mula R; Arigita M; Grande M; Gonce A; Borobio V; Borrell A
    Fetal Diagn Ther; 2013; 34(2):116-20. PubMed ID: 23817147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomy 21 during the routine second-trimester ultrasound examination in an unselected Chilean population.
    Parra-Cordero M; Quiroz L; Rencoret G; Pedraza D; Muñoz H; Soto-Chacón E; Miranda-Mendoza I
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):946-51. PubMed ID: 17987599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone.
    Orlandi F; Rossi C; Orlandi E; Jakil MC; Hallahan TW; Macri VJ; Krantz DA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1107-11. PubMed ID: 15846188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal bone in first-trimester screening for trisomy 21.
    Cicero S; Avgidou K; Rembouskos G; Kagan KO; Nicolaides KH
    Am J Obstet Gynecol; 2006 Jul; 195(1):109-14. PubMed ID: 16813749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester ultrasound assessment of the nasal bone to screen for aneuploidy.
    Rosen T; D'Alton ME; Platt LD; Wapner R;
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):399-404. PubMed ID: 17666617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia?
    Cusick W; Shevell T; Duchan LS; Lupinacci CA; Terranova J; Crombleholme WR
    Ultrasound Obstet Gynecol; 2007 Sep; 30(3):271-4. PubMed ID: 17721915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.